Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 20, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 13 May 2026 - 8:41

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 20, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rivastigmine-hexal

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters